Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mikiko Unesoko"'
Publikováno v:
Surgical Case Reports, Vol 8, Iss 1, Pp 1-4 (2022)
Abstract Background Many oncoplastic volume replacement techniques have been reported, however, it is generally difficult to utilize a single distant flap for bilateral breast carcinomas. Case presentation We report a case of bilateral multiple breas
Externí odkaz:
https://doaj.org/article/a779e11083ab49a7b1495659dc6dff66
Autor:
Hirofumi Matsumoto, Akiko Ishii, Norihiro Nakada, Ayako Koki, Mikiko Unesoko, Norie Abe, Hisamitsu Zaha
Publikováno v:
Virchows Archiv. 480:739-748
Preoperative evaluations of the size of ductal carcinoma in situ (DCIS) extension in invasive breast cancer (IBC) are problematic and markers of the actual size of DCIS remain elusive. This study aimed to quantify DCIS on core needle biopsy (CNB) and
Autor:
Naoki Yoshimi, Akiko Ishii, Puay Hoon Tan, Norie Abe, Reika Takamatsu, Norihiro Nakada, Hiroshi Nishihara, Hirofumi Matsumoto, Mikiko Unesoko, Hisamitsu Zaha
Publikováno v:
Virchows Archiv. 479:401-405
Breast spiradenoma is extremely rare, with only 4 cases reported previously. We describe an instructive case of breast spiradenoma resembling adenoid cystic carcinoma (AdCC). A 71-year-old woman underwent excisional biopsy of a breast mass after a co
Publikováno v:
Cancer Research. 77:P3-13
Background:There are several small case series about the omental flap for breast reconstructions. However, the long-term oncological safety and the clinical benefits remain uncertain, especially the flap is used as a part of oncoplastic breast surger
Publikováno v:
Breast Cancer Research and Treatment. 162:267-274
There are several small case series on use of a laparoscopically harvested omental flap (LHOF) for breast reconstruction. However, the long-term oncological safety and clinical benefits of the LHOF remain uncertain, especially in use of the flap in o
Autor:
Tatsunori Shimoi, Reiko Yoshie, Tokiwa Motonari, Mikiko Unesoko, Taisei Mushiroda, Kenji Tamura, Hisamitsu Zaha, Hiromi Sakamoto, Koichiro Tsugawa, Masayuki Yoshida, Teruhiko Yoshida, Yasuyuki Kojima, Ken Kato, Mari Hara Nakano, Hitoshi Zembutsu, Norie Abe, Arata Shimo, Chihiro Udagawa
Publikováno v:
Biologicalpharmaceutical bulletin. 42(12)
Trastuzumab has been administered to patients with human epidermal growth factor receptor 2 (HER2)-positive cancer, however, the cardiotoxicity is identified as one of the life-threatening toxicities. Clinically useful biomarker for trastuzumab-induc
Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer
Autor:
Mikiko Unesoko, Naoki Yoshimi, Kano Uehara, Kentaro Tamaki, Yoshihiko Kamada, Norie Abe, Reika Takamatsu, Nobumitsu Tamaki, Hirofumi Matsumoto, Norihiro Nakada, Tokiwa Motonari, Hisamitsu Zaha, Naoko Takigami
Publikováno v:
Virchows Archiv : an international journal of pathology. 476(5)
As visual quantification of the density of tumor-infiltrating lymphocytes (TILs) lacks in precision, digital image analysis (DIA) approach has been applied in order to improve. In several studies, TIL density has been examined on hematoxylin and eosi
Publikováno v:
Breast cancer (Tokyo, Japan). 27(4)
The modified round block technique (MRBT) is a level I oncoplastic breast-conserving surgery (OBCS), which contains a very wide glandular flap created by extensive dual-plane undermining that is achieved by entire subcutaneous dissection and approxim
Autor:
Chihiro Udagawa, Mari Hara, Arata Shimo, Yasuyuki Kojima, Reiko Yoshie, Hisamitsu Zaha, Norie Abe, Tokiwa Motonari, Mikiko Unesoko, Kenji Tamura, Tatsunori Shimoi, Masayuki Yoshida, Teruhiko Yoshida, Hiroshi Okamura, Taisei Mushiroda, Koichiro Tsugawa, Hitoshi Zembutsu
Publikováno v:
Cancer Research. 79:2951-2951
Purpose: Trastuzumab has been administered to HER2-positive breast or gastric cancer patients as an effective treatment, however, the cardiotoxicity is identified as one of the life-threatening side effects. To identify a novel genetic marker(s) dete
Publikováno v:
Breast Cancer Research and Treatment. 163:411-412